Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$3.04B |
| 2 |
Netflix
NFLX
|
+$2.17B |
| 3 |
Amgen
AMGN
|
+$775M |
| 4 |
Baker Hughes
BKR
|
+$677M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$676M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WP
Worldpay, Inc.
WP
|
+$2.91B |
| 2 |
Lowe's Companies
LOW
|
+$1.97B |
| 3 |
Intel
INTC
|
+$1.3B |
| 4 |
Altria Group
MO
|
+$961M |
| 5 |
Marriott International
MAR
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.42% |
| 2 | Technology | 18.27% |
| 3 | Communication Services | 11.95% |
| 4 | Consumer Discretionary | 11.79% |
| 5 | Industrials | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Ingevity
NGVT
$2.61B
| $63.5M | 0.02% |
748,500
+731,692
| +4,353% | +$65.2M |
|
|
DHR.PRA
302
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $62.6M | 0.02% |
54,900
| – | – |
|
303
CarMax
KMX
$8.43B
| $61.7M | 0.02% |
+701,425
| New | +$60.2M |
|
304
Quince Therapeutics
QNCX
$33.9M
| $60.1M | 0.02% |
+12,215
| New | +$75.2M |
|
305
UBS Group
UBS
$176B
| $59.7M | 0.02% |
5,257,745
-16,446,439
| -76% | -$185M |
|
306
McCormick & Company Non-Voting
MKC
$14.6B
| $58.8M | 0.02% |
752,666
-18
| -0% | -$1.45K |
|
|
WMGI
307
DELISTED
Wright Medical Group Inc
WMGI
| $58.5M | 0.02% |
2,836,005
-1,291,906
| -31% | -$30.7M |
|
|
X
308
DELISTED
US Steel
X
| $58.2M | 0.02% |
+5,039,000
| New | +$64.9M |
|
|
GOOS
309
Canada Goose Holdings
GOOS
$848M
| $56.7M | 0.02% |
1,289,654
| – | – |
|
310
NiSource
NI
$20.2B
| $56.1M | 0.02% |
1,873,384
-2,095,917
| -53% | -$61.5M |
|
|
FISV
311
Fiserv Inc
FISV
$28.4B
| $55.6M | 0.02% |
536,700
| – | – |
|
312
CAE Inc. Common Shares
CAE
$8.43B
| $55.5M | 0.02% |
2,182,570
+1,301,570
| +148% | +$34.2M |
|
|
COUP
313
DELISTED
Coupa Software Incorporated
COUP
| $54.8M | 0.02% |
423,120
| – | – |
|
314
Pfizer
PFE
$153B
| $53.9M | 0.02% |
1,582,467
-57
| -0% | -$2.07K |
|
315
PTC
PTC
$16B
| $53.8M | 0.02% |
+788,881
| New | +$57.6M |
|
316
M&T Bank
MTB
$36.8B
| $52.7M | 0.02% |
333,600
| – | – |
|
317
Freshpet
FRPT
$3.49B
| $52.7M | 0.02% |
+1,058,608
| New | +$48.4M |
|
318
Cognex
CGNX
$10.3B
| $51.6M | 0.02% |
1,050,000
| – | – |
|
319
Silicon Laboratories
SLAB
$7.29B
| $51.6M | 0.02% |
463,000
| – | – |
|
320
Yum! Brands
YUM
$41.3B
| $51.5M | 0.02% |
454,244
-777,183
| -63% | -$88.8M |
|
321
MakeMyTrip
MMYT
$5.64B
| $51.5M | 0.02% |
2,269,437
-3,621
| -0.2% | -$88.9K |
|
|
PRMW
322
DELISTED
Primo Water Corporation
PRMW
| $51.1M | 0.02% |
4,160,557
+467,000
| +13% | +$6.05M |
|
|
LOMA
323
Loma Negra
LOMA
$1.11B
| $51.1M | 0.02% |
8,880,782
+127,000
| +1% | +$1.07M |
|
324
PPG Industries
PPG
$25.5B
| $50.3M | 0.02% |
424,383
| – | – |
|
|
JOYY
325
JOYY Inc
JOYY
$3.62B
| $48.1M | 0.02% |
855,972
-163
| -0% | -$9.9K |
|
Similar funds
Capital Research Global Investors's Q3 2019 Portfolio in Review
As of Q3 2019, Capital Research Global Investors held 439 positions worth $305B, down 3.2% from $315B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capital Research Global Investors's Q3 2019 filing shows 39 new, 167 increased, 156 reduced and 25 closed positions. Its largest new stake was Fidelity National Information Services: 22,895,290 shares worth $3.04B. The largest sale was Worldpay, Inc., an estimated $2.91B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q3 2019 buy was Fidelity National Information Services: 22,895,290 shares worth $3.04B.
- Capital Research Global Investors added most to Netflix in Q3 2019, an estimated $2.17B increase.
- Capital Research Global Investors's biggest Q3 2019 reduction was Lowe's Companies, cutting an estimated $1.97B.
- Capital Research Global Investors fully exited Worldpay, Inc. in Q3 2019, selling an estimated $2.91B.
- Capital Research Global Investors's ten largest holdings make up 27% of its $305B portfolio in Q3 2019.
- Capital Research Global Investors opened 39 new positions and closed 25 in Q3 2019.
- Capital Research Global Investors's portfolio value fell 3.2% quarter-over-quarter to $305B.
Based on Capital Research Global Investors's 13F filing for Q3 2019, filed 14 Nov 2019.